Lupin logo

LUPIN - Lupin News Story

₹1079.45 30.2  2.9%

Last Trade - 09/04/21

Sector
Healthcare
Size
Large Cap
Market Cap £4.78bn
Enterprise Value £4.99bn
Revenue £1.49bn
Position in Universe 83rd / 3106

BRIEF-Lupin Receives Approval For Sevelamer Carbonate Tablets

Mon 25th January, 2021 6:49am
Jan 25 (Reuters) - Lupin Ltd  LUPN.NS :
    * RECEIVES APPROVAL FOR SEVELAMER CARBONATE TABLETS

Source text for Eikon:  ID:nBSE5Grfz3 
Further company coverage:  LUPN.NS 

 ((bangalore.newsroom@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.